Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc monthly Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E11.78 EPS (ttm)3.50 Insider Own0.20% Shs Outstand2.49B Perf Week0.54%
Market Cap102.97B Forward P/E13.59 EPS next Y3.03 Insider Trans0.00% Shs Float2.48B Perf Month-1.81%
Income8.78B PEG3.27 EPS next Q0.86 Inst Own12.80% Short Float0.41% Perf Quarter0.81%
Sales46.01B P/S2.24 EPS this Y31.60% Inst Trans2.48% Short Ratio3.26 Perf Half Y-5.92%
Book/sh7.18 P/B5.74 EPS next Y1.44% ROA8.00% Target Price47.70 Perf Year3.81%
Cash/sh4.34 P/C9.49 EPS next 5Y3.60% ROE53.60% 52W Range31.43 - 48.25 Perf YTD-12.34%
Dividend1.89 P/FCF17.24 EPS past 5Y10.30% ROI14.30% 52W High-14.63% Beta0.69
Dividend %4.59% Quick Ratio0.70 Sales past 5Y8.00% Gross Margin68.00% 52W Low31.05% ATR0.75
Employees99437 Current Ratio1.00 Sales Q/Q-2.40% Oper. Margin25.50% RSI (14)50.91 Volatility0.92% 1.36%
OptionableYes Debt/Eq2.33 EPS Q/Q133.30% Profit Margin19.10% Rel Volume0.92 Prev Close42.16
ShortableYes LT Debt/Eq1.89 Earnings- Payout10.70% Avg Volume3.10M Price41.19
Recom2.00 SMA200.29% SMA500.27% SMA200-3.11% Volume2,848,143 Change-2.30%
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Aug-13-20 05:19PM  
04:03PM  
07:00AM  
03:25AM  
Aug-12-20 03:25PM  
08:07AM  
Aug-11-20 05:05PM  
Aug-10-20 12:08PM  
08:38AM  
Aug-09-20 05:30AM  
Aug-07-20 12:15PM  
11:30AM  
06:00AM  
Aug-06-20 01:42PM  
12:54PM  
08:13AM  
07:57AM  
03:59AM  
Aug-05-20 11:38PM  
09:52PM  
09:08PM  
04:14PM  
10:20AM  
10:06AM  
Aug-04-20 05:23PM  
11:50AM  
09:21AM  
Aug-03-20 07:00AM  
04:23AM  
Aug-02-20 09:07AM  
07:39AM  
06:39AM  
Aug-01-20 06:49AM  
06:33AM  
Jul-31-20 06:42PM  
04:55PM  
04:35PM  
03:51PM  
03:40PM  
12:44PM  
12:19PM  
09:25AM  
07:55AM  
07:47AM  
07:33AM  
07:25AM  
07:07AM  
07:00AM  
07:00AM  
Jul-30-20 11:47AM  
Jul-29-20 11:03PM  
09:35PM  
05:21PM  
10:38AM  
10:03AM  
09:53AM  
09:18AM  
09:13AM  
09:08AM  
07:52AM  
07:32AM  
07:12AM  
05:23AM  
03:31AM  
01:02AM  
Jul-27-20 10:00AM  
Jul-26-20 06:48AM  
Jul-24-20 07:01PM  
02:06PM  
11:18AM  
10:27AM  
06:46AM  
Jul-23-20 05:05PM  
03:55PM  
Jul-22-20 09:58AM  
Jul-21-20 11:29AM  
11:04AM  
07:46AM  
Jul-20-20 04:02PM  
08:00AM  
06:28AM  
05:11AM  
04:46AM  
04:26AM  
Jul-19-20 08:37AM  
Jul-17-20 11:06AM  
04:13AM  
Jul-16-20 11:29AM  
09:22AM  
Jul-15-20 11:34AM  
10:18AM  
07:30AM  
07:28AM  
07:00AM  
Jul-14-20 05:46PM  
04:18PM  
09:23AM  
08:00AM  
Jul-13-20 06:33PM  
01:41PM  
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCDirectorJul 21Buy18.00361,1116,499,9982,248,304Jul 22 04:18 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerOct 18Buy28.00357,1429,999,9762,982,855Oct 22 05:36 PM
GLAXOSMITHKLINE PLCDirectorSep 10Buy45.00177,7777,999,9652,170,327Sep 12 04:18 PM